Abivax appoints Alexandra Pearce as VP of...Dr. Pearce Joins as ABIVAX Works with FDA and EMA on Next Stage Developments of its Clinical Product Candidates more ➔
Commense Appoints Edward J. Stewart as Pre...Commense, Inc., an affiliate of PureTech Health plc developing microbiome-derived immune modulators for paediatric and maternal health, today announced the appointment of Edward J. Tad Stewart as … more ➔
Nordic Nanovector’s Luigi Costa to s...Nordic Nanovector ASA announces that Luigi Costa will step down as Chief Executive Officer by mutual agreement with the Board of Directors. A search for a new CEO will begin immediately. To ensure a … more ➔
Namal Nawana appointed CEO of Smith &...Smith & Nephew plc today announced the appointment of Namal Nawana as Chief Executive Officer. He will join the Company and be appointed to the Board as an Executive Director on 7 May 2018. more ➔
Abeona Therapeutics Appoints Carsten Thiel...Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of … more ➔
Rentschler appoints Dr. Thomas RöschRentschler Biopharma SE announced today that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018. He will be responsible for advanced … more ➔
Søren Tulstrup appointed CEO of Hansa Med...Hansa Medical AB, a biopharmaceutical company developing novel immunomodulatory enzymes, today announced that the board of directors have appointed Søren Tulstrup as new President and CEO of Hansa Medical … more ➔
Domainex appoints Dr Bodo SporiDomainex Ltd, a privately-owned drug discovery services company, has announced the appointment of Dr Bodo Spori as Head of Business Development for Europ. more ➔
SP Industries Announces Brian Larkin as Pr...SP Industries Inc. has announced the appointment of Brian Larkin as its President and Chief Executive Officer effective February 19th, replacing William (Bill) Downs who recently retired. more ➔
David Colpman joins Forendo Pharma’s...Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, today announces the appointment of David Colpman as a non-executive director to its Board of Directors. more ➔